Oral cancer patients given the curcumin containing drug APG-157, which also contains several other polyphenolic compounds, showed a reduction of the inflammatory cytokines IL-1β, IL-6, and IL-8 in salivary fluid, accompanied with elevated immune T cells in the tumor tissue, suggesting its potential use in combination with immunotherapy (328). The gene discussed is IL6; the disease is lip and oral cavity carcinoma.